Search
Sign Up
Home
Team
Pipeline
Back
Sr89/Metastron
QBM-001
Uttroside-B
MAN-01
Investors
Back
Presentations
Stock Info
Filings
Media
News
Back
News 2024
News 2023
News 2022
News 2021
News 2020
News 2019
News 2018
News 2017
News 2016
Contact
Video & Social Media
Watch us in interviews. Follow us.
News 2018
List of articles in category News 2018
Title
Created Date
Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children
Dec 12, 2018
Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare
Nov 28, 2018
Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference
Oct 26, 2018
Q BioMed Provides Important Update on QBM001 Developmental Drug Targeting a Non-Verbal and Minimally Verbal Patient Subset on the Autism Spectrum
Oct 09, 2018
Q Biomed Inc. Announces Entry Into Definitive Funding Agreement for $4,000,000
Sep 24, 2018
Q Biomed Inc. Announces Dr. Rajendra Apte Joins Advisory Board
Sep 17, 2018
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
Aug 20, 2018
Q Biomed Inc. Extends its Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma and Initiates a Clinical Study
Jul 25, 2018
Q BioMed Inc Places 2nd in Company Category for Autism Speaks Walk Fundraiser
Jun 01, 2018
Q Biomed Inc. to Present at the Microcap Conference Taking Place April 9-10 at the Essex House in New York City
Apr 05, 2018
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain
Mar 16, 2018
Q BioMed Inc. to Present at 30th Annual Roth Conference, Taking Place March 11-14, 2018, in Dana Point, CA
Mar 09, 2018
Washington University researchers evaluate biomarker for glaucoma
Feb 28, 2018
Q BioMed Adds Big Pharma Executive to Board of Directors
Feb 13, 2018
Q Biomed Inc. Signs Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma
Feb 08, 2018
Q Biomed Inc. Closes $5.48 Million Public Offering
Feb 01, 2018
Q BioMed Inc. Prices $5.5 Million Public Offering
Jan 30, 2018
Q Biomed Inc. to Present at Biotech Showcase(™) 2018
Jan 03, 2018